Increase Success Rate in Cancer Drug Trials: Medic Life Sciences [Genomics Startups #5]

17 de feb. de 2021 · 15m 48s
Increase Success Rate in Cancer Drug Trials: Medic Life Sciences [Genomics Startups #5]
Descripción

Their mission is to make cancer drugs survive and resurrect from devastated clinical trials in which 93% of cancer drugs are failed. They have a proprietary technology that can produce...

mostra más
Their mission is to make cancer drugs survive and resurrect from devastated clinical trials in which 93% of cancer drugs are failed. They have a proprietary technology that can produce 2 million different tumor samples to test pre-clinical cancer drugs. This technique is based on generating massive 3D organoids and whole-genome editing of cancer organoids by CRISPR.

*

This is a special "limited series" of 6 episodes focusing on genomics startups. In partnership with the Illumina Accelerator based in Cambridge and SF Bay Area, we have interviewed six genomics, life-sciences, and biotech startups, 2 in the UK and 4 in the US.

We will be following a 5-step Heroes' Journey structure for these startups. In each video, you can see the marked chapters at the bottom of the screen.

Getting to know our heroes,
Hear the "starting-up" story,
Paths crossing with the accelerator,
Toughest decisions they had to make,
Big learning moments and the future direction.

*

https://twitter.com/startupsoflndn
https://www.linkedin.com/company/startupsoflondon
https://www.instagram.com/startupsoflndn/
mostra menos
Información
Autor SOL Labs
Página web -
Etiquetas

Parece que no tienes ningún episodio activo

Echa un ojo al catálogo de Spreaker para descubrir nuevos contenidos.

Actual

Portada del podcast

Parece que no tienes ningún episodio en cola

Echa un ojo al catálogo de Spreaker para descubrir nuevos contenidos.

Siguiente

Portada del episodio Portada del episodio

Cuánto silencio hay aquí...

¡Es hora de descubrir nuevos episodios!

Descubre
Tu librería
Busca